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ABSTRACT
Objective: In recent years, an increasing frequency and severity of antimicrobial resistance to different antimicrobial agents, demands new remedies 
for the treatment of infections. Therefore, in this study, a series of undec-10-enehydrazide derivatives were synthesized and screened for in vitro 
activity against selected pathogenic microbial strains.
Methods: The synthesis of the intermediate and target compounds was performed by standard procedure. Synthesized compounds were screened for 
antimicrobial activity by tube dilution method. Molecular docking study of synthesized derivatives was also performed to find out their interaction with 
the target site of β-ketoacyl-acyl carrier protein synthase III, (FabH; pdb id:3IL7) by docking technique. Quantitative structure–activity relationship 
(QSAR) studies were also performed to correlate antimicrobial activity with structural properties of synthesized molecules.
Results: Antimicrobial screening results showed that compound 8 having benzylidine moiety with methoxy groups at meta and para position and 
compound 16 having 3-chloro-2-(3-flourophenyl)-4-oxoazetidine moiety was found to be most potent. QSAR studies revealed the importance of 
Randic topology parameter (R) in describing the antimicrobial activity of synthesized derivatives. Molecular docking study indicated hydrophobic 
interaction of deeply inserted aliphatic side chain of the ligand with FabH. The N-atoms of hydrazide moiety interacts with Ala246 and Asn247 
through H-bonding. The m- and p-methoxy groups form H-bond with water and side chain of Arg36, respectively.
Conclusion: Compound 8 having benzylidine moiety with methoxy groups at meta and para position and compound 16 having 3-chloro-2-(3-
flourophenyl)-4-oxoazetidine moiety was found to most potent antibacterial and antifungal compounds, respectively.
Keywords: Antibacterial, Antifungal molecular docking, Biological evaluation, Undec-10-enoic acid derivative.
INTRODUCTION
Antimicrobial resistance (AMR) is an increasingly serious health 
problem worldwide. It causes difficulty in the successful treatment and 
prevention of an ever-growing infectious disease, caused by bacteria, 
fungi, parasites, and viruses [1]. Due to resistant microbial strains, 
the cost of treatment is much more as compared to treatment caused 
by nonresistant strains. The treatment has to continue for the longer 
duration of time with additional diagnostic tests and comparatively 
higher cost of drugs [2,3]. Hence, AMR threat demands synthesis of new 
effective antibiotics against resistant microbial strains.
Undec-10-enoic (undecylenic acid) is 11 carbon straight chain 
unsaturated fatty acid, synthesized by cracking of castor oil under 
pressure. It is a natural fungicide, used for the treatment of skin infections 
such as athlete’s foot, ringworm and jock itch. Undecylenic acid also 
has antiviral properties effective in skin infections caused by herpes 
simplex [4]. Reported data suggested that undec-10-enoic acid and their 
derivatives can make a complex with iron ions, which afford an effective 
mechanism to stop the bacterial growth [5]. Further, the previous 
studies performed by us revealed the significance of different acid 
derivatives, including undec-10-enoic hydrazide-hydrazone derivatives 
as antibacterial and antifungal agents [6-11]. Studies reported by 
various research groups also showed that hydrazide-hydrazone 
derivatives of different acids have wide range of biological activities, viz., 
antibacterial [12], antifungal [13], antitubercular [14], trypnocidal [15], 
antimalarial [16], antiviral [8], anti-inflammatory [17], and 
antitumor [18] activities. Isoniazid (antitubercular) [19], nifuroxazide 
(antidiarrheal and antitumor) [20], nifurtimox (antiamoebic) [21], 
furacin (antibiotic) [22], and furazolidone (antibacterial) [23] are 
hydrazide containing important biologically active drug molecules. 
Moreover, SAR studies indicated that substitution at a specific position 
in aromatic ring attached to hydrazide moiety and conversion of 
hydrazide moiety to hydrazone/pyrazole/oxadiazole/4-oxoazitidine 
based molecules affect the biological activity to a great extent [9,24,25]. 
Based on aforementioned observations and in continuation of our 
ongoing research program [6-11], hydrazide-hydrazone derivatives of 
undec-10-enoic were synthesized and evaluated for their antimicrobial 
activity against Escherichia coli, Bacillus subtilis, Staphylococcus aureus, 
Aspergillus niger, and Aspergillus fumigatus by tube dilution method.
Based on efficient predicting ability of quantitative structure–activity 
relationship (QSAR) method of closely related analogs [26] and 
to correlate antimicrobial activities with structural parameters of 
synthesized molecules, one-target QSAR (ot-QSAR) and multi-target 
QSAR (mt-QSAR) models were developed. Molecular docking studies 
were also carried out to understand the binding pattern and to support 
in vitro antimicrobial data of synthesized most active compound [27,28]. 
Automated docking technique was used to determine the orientation 
of inhibitors, bound in the active site of β-ketoacyl-acyl carrier protein 
synthase III (FabH; pdb id:3IL7) [29]. β-ketoacyl-acyl carrier protein 
synthase encoded by the fabH gene is reported to catalyze the first 
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elongation reaction (Claisen condensation) of type II fatty acid synthesis 
and responsible for the synthesis of long chain fatty acid structures, 
present in bacteria and fungi [30-32].
EXPERIMENTAL
Progress and completion of the reaction were monitored by thin layer 
chromatography (TLC) on silica gel sheets (Merck silica gel-G). Melting 
points were determined in open glass capillaries on Popular India 
melting point apparatus. 1H nuclear magnetic resonance (1H NMR) 
spectra were recorded on Bruker Avance II 400 NMR spectrometer 
(400 MHz) at 298 K, in appropriate deuterated solvents. Chemical shifts 
were reported as δ (ppm) relative to tetramethylsilane as an internal 
standard. Infrared spectra (IR) were recorded as KBr pellet on Shimadzu 
FTIR spectrometer. The wave number is given in 120 cm−1. Mass spectra 
were recorded on Waters Micromass Q-TOF Micro instrument.
Synthetic procedure for synthesis of undecylenic acid hydrazide 
derivatives (Schemes 1 and 2)
Synthesis of methyl undec-10-enoate (2) from undecylenic acid (1)
An ethanolic mixture of (0.05 mol) of undecylenic acid (1) was refluxed 
in the presence of concentrated sulfuric acid (4-5 drops) for 4 hrs. The 
completion of reaction was confirmed by TLC. The excess of acid was 
neutralized with sodium bicarbonate. Then, synthesized crude ester 
was extracted by adding diethyl ether and water in separating funnel. 
Ester (2) was obtained by evaporating diethyl ether layer. Moisture of 
ester was removed by sodium sulphate. Synthesized crude ester was 
recrystallized using ethanol.
Synthesis of undec-10-ene hydrazide (3) from methyl undec-10-
enoate (2)
Solution of methyl undec-10-enoate (0.02 mol) and hydrazine hydrate 
(0.058 mol) was refluxed in ethanol for 14 hrs. Reaction mixture was 
cooled and precipitate of undec-10-enehydrazide was collected and 
recrystallized from ethanol.
Synthesis of benzylideneundec-10-enehydrazide derivatives (4-13) 
from undec-10-ene hydrazide (3)
Mixture of undec-10-ene hydrazide (3) (0.005 mol) and equimolar 
amount of appropriate substituted benzaldehydes/acetophenone in 
ethanol was refluxed for 7-8 hrs. The excess of ethanol was evaporated. 
Precipitated compounds (4-13) were filtered off and washed with hexane.
Synthesis of N-(3-chloro-2-oxo-4-phenylazetidin-1-yl)undec-
10-enamide derivatives (14-16) from benzylideneundec-10-
enehydrazide (4-6)
Chloroacetyl chloride (0.01 mol) was added to a mixture of triethylamine 
(0.01 mol) and benzylideneundec-10-enehydrazide(0.01 mol) in 1, 
4-dioxane (40 ml) with stirring at 0-5°C for 1 hr followed by stirring 
for 3 hrs at room temperature. The completion of reaction was checked 
by TLC. Excess solvent was evaporated and synthesized azetidinone 
derivatives (14-16) were washed with hexane. Mixture of both form of 
stereoisomer was obtained.
Synthesis of 3-methyl-1-(undec-10-enoyl)-1H-pyrazol-5(4H)-one 
(17) from undec-10-ene hydrazide (3)
A solution of undec-10-enehydrazide (3) (0.005 mol) and ethyl 
acetoacetate (0.08 mol) in ethanol was refluxed for 16 hrs. Reaction 
mixture was cooled and the precipitates of 3-methyl-1-(undec-10-
enoyl)-1H-pyrazol-5(4H)-one (17) was filtered off and washed with 
mixture of toluene and ethanol (4.5: 0.5).
Synthesis of 2-methyl-5-(undec-10-en-1-yl)-1,3,4-oxadiazole (18) 
from undec-10-ene hydrazide (3)
Ethanolic solution of undec-10-enehydrazide (3) (0.005 mol) was 
refluxed for 8 hrs with acetic anhydride (0.048 mol). Completion of the 
reaction was confirmed by TLC. Final liquid product (18) was obtained 
after evaporation of excess of solvent on water bath.
Synthesis of N’-acetylundec-10-enehydrazide (19) from undec-
10-ene hydrazide (3)
Ethanolic solution of undec-10-enehydrazide (3) (0.005 mol) was refluxed 
for 8 hrs in acetic acid (0.049 mol) and acetic anhydride (0.049 mol). 
Reaction mixture was cooled and the precipitates of N’-acetyldec-9-
enehydrazide (19) was filtered off and recrystallized with ethanol.
Spectral data
Methyl undec-10-enoate (2)
Bp (°C) 103-108; yield 80%; 1H NMR (400 MHz, CDCl3) δ: 5.57-5.67 (m, 
1H, C10), 4.73- 4.83 (d, 2H), 3.48 (s, 3H), 2.09-2.15 (q, 2H), 1.85-1.90 
(t, 2H), 1.42-1.47 (m, 2H), 1.06-1.24 (m, 10H). IR (KBr pellets) cm−1: 
3076.56 (C-H str., alkenes), 2928.04 (C-H str., aliphatic), 1741.78 (C=O 
str.), 1641.48 (C=C str., alkenes), 1460.16 (C-H bending, aliphatic), 
993.37 (C-H bending, alkenes).
Undec-10-ene hydrazide (3)
Mp (°C) 88-93; yield 72%; 1H NMR (400 MHz, CDCl3) δ: 7.49 (s, 1H), 
5.68-5.78 (m, 1H), 4.83-4.94 (d, 2H), 3.88 (s, 2H), 2.07-2.11 (t, 2H), 1.93-
1.99 (m, 2H), 1.18-1.31 (m, 10H). IR (KBr pellets) cm−1: 3317.61(NH 
str.), 3045.70 (C-H str., alkenes), 2920.32 (C-H str., aliphatic), 1664.27 
(C=C, alkenes), 1631.83 (C=O str.), 1537.32 (NH bending), 1462.02 (C-H 
bending, aliphatic), 912.36 (C-H bending, alkenes).
N′-benzylideneundec-10-enehydrazide (4)
Mp (°C) 88-93; yield 64%; 1H NMR (400 MHz, dimethyl sulfoxide 
[DMSO]): δ 10.72 (s, NH), 9.80 (s, 1H), 7.52-7.83 (m, 5H), 5.00-5.83 (m, 
1H), 4.90-4.99 (m, 2H), 2.00-2.78 (t, 2H), 1.92 (m, 2H), 1.25-1.92 (q, 2H), 
1.18-1.23 (m, 10H),. IR (KBr pellets) cm−1: 3443.05 (NH str.), 3190.37 
(C-H aromatic) 3022.55 (C-H str., alkenes), 2918.40 (C-H str., alkane), 
2364.81 (C=N, nitriles), 1668.48 (C=O str.), 1649.19 (C=C str. alkenes), 
1606.76 and 1465.95 (C=C, aromatic), 958.65(C-H bending, alkenes), 
1448.59 (C-H bending, alkane) MS ES+ (ToF): m/z 287.2 [M+ + 1].
N’-(3-nitrobenzylidene) undec-10-enehydrazide (5)
Mp (°C) 115-120; yield 72%; 1H NMR (400 MHz, CDCl3) δ: 10.52 (s, 
1H), 8.27-8.2 (d, 2H), 7.92 (s, 1H), 7.82-7.84 (d, 2H), 5.75-5.83 (m, 1H), 
4.95-5.01 (d, 1H), 4.91-4.94 (d, 1H), 2.77-2.81 (t, 2H), 2.10 (q, 2H), 1.71-
1.78 (m, 2H), 1.23-1.46 (m, 10H). IR (KBr pellets) cm−1: 3446.91 (NH 
str.), 3115.14 (C-H str., aromatic), 2924.18 (C-H str., alkenes), 2850.88 
(C-H str., alkane), 2360.95 (C=N str.), 1668.48 (C=O str.), 1583.61 (NH 
bending), 1521.89 and 1338.64 (N=O str.), 1597.11 and 1467.88 (C=C, 
aromatic).
N′-(3-fluorobenzylidene)undec-10-enehydrazide (6)
Mp (°C) 210-215; yield 50%; 1H NMR (400 MHz, CDCl3) δ: 9.67 (s, 1H), 
7.31-7.37 (d, 2H), 7.21 (s, 1H), 6.87-6.91 (d, 2H), 5.60-5.63 (m, 1H), 
4.65-4.80 (d, 1H), 4.72-4.75 (m, 1H), 2.70-2.75 (t, 2H), 2.00 (q, 2H), 
1.62-1.67 (m, 2H), 1.24-1.49 (m, 10H). IR (KBr pellets) cm−1: 3443.05 
(NH str.), 2926.11 (C-H str., alkenes), 2852.81 (C-H str., alkane), 2364.81 
(C=N, nitriles), 1400.37 and 1321.28 (C-H bending, alkane), 1633.76 
(C=O str.), 1294.28 (C-F), 964.44 (C-H bending, alkenes), 794.70 (C-H 
bending, aromatic).
N′-(3, 4-dimethoxybenzylidene)undec-10-enehydrazide (8)
Mp (°C) 210-215; yield 50%;1H NMR (400 MHz, DMSO): δ 9.80 (s, NH), 
7.02-7.88 (m, 4H), 5.71-5.80 (m, 1H), 4.89-4.99 (d, 2H), 2.17-2.26 (m, 
2H), 1.58-1.65 (m, 2H), 1.18-1.32(m, 10H), 3.36 (s, 2H), 3.73 (s, 6H), 
3.82 (s, 2H). IR (KBr pellets) cm−1: 3468.13 (NH str.), 3196.15 (C-H str., 
aromatic), 3047.63 (C-H str., alkenes), 2922.25 (C-H str., alkane), 1658.84 
(C=O str.), 1600.97 (C=C, aromatic), 1462.09 & 1384.94 (C-H bending, 
alkane), 1271.13 (C-O-C asym. str.), 1139.97 (C-N), 1107.18 (C-O-C sym. 
str.), 904.64 (C-H bending, alkenes). MS ES+ (ToF): m/z 347.2 [M+ + 1].
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N′-(3-hydroxy-4-methoxybenzylidene)undec-10-enehydrazide (9)
Mp (°C) 104-109; yield 55%; 1H NMR (400 MHz, DMSO): δ 10.99 (s, 2H), 
9.77 (s, NH), 6.80-7.03 (m, 4H), 5.89-5.67 (m, 1H), 4.90-4.99 (m, 2H), 
3.80 (s, 3H), 2.16-2.20 (t, 2H), 1.96-1.98 (m, 2H), 1.19-1.62 (m, 10H). IR 
(KBr pellets) cm−1: 3471.98 (NH str.), 3238.59 (OH str.), 3196.15 (C-H 
str., aromatic), 3053.42 (C-H str., alkenes), 2924.18 (C-H str., alkane), 
2360.95 (C=N), 1656.91 (C=O str.), 1600.97 (C=C, aromatic), 1273.06 
(C-O-C asym. str.), 1213.27 (C-N), 1122.61 (C-O-C sym. str.), 964.44 (C-H 
bending, alkenes).
N′-(4-ethoxy-3-hydroxybenzylidene)undec-10-enehydrazide (10)
Mp (°C) 215-220; yield 65%; 1H NMR (400 MHz, DMSO): δ 5.71-5.82 (m, 
1H), 4.02-4.12 (m, 2H), 3.80 (s, 3H), 6.80-6.99 (m, 6H), 2.00-2.20 (m, 
2H), 1.57-1.64 (m, 2H), 1.19-1.43 (m, 10H), 9.75 (s, NH), 10.96 (s, 2H). 
IR (KBr pellets) cm−1: 3435.34 (NH str.), 3572.29 (OH str.), 3236.66 (C-H 
str., aromatic), 3076.56 (C-H str., alkenes), 2924.18 (C-H str., alkane), 
2333.94 (C=N), 1658.84 (C=O str.), 1631.83 (C=C str., alkenes), 1600.97 
(C=C, aromatic), 1290.42 (C-O-C asym. str.), 1213.27 (C-N), 1122.61 
(C-O-C sym. str.), 966.37 (C-H bending, alkenes), 1438.98 and 1392.65 
(C-H bending, alkane).
N′-(3,5-dihydroxybenzylidene)undec-10-enehydrazide (13)
Mp (°C) 145-150; Yield 68%; 1H NMR (400 MHz, DMSO): δ 5.00 (m, 1H), 
4.90-4.99 (m, 2H), 7.69-7.76 (m, 4H), 1.90-1.92 (m, 2H), 2.18-2.22 (t, 
2H), 1.57-1.63 (q, 2H), 1.17-1.31(m, 10H), 9.79 (s, 1H), 11.13 (s, 1H). 
%; IR (KBr pellets) cm−1: 3527.92 (OH str.), 3203.87 (NH str.), 3171.08 
(C-H str., aromatic), 2916.47 (C-H str., alkenes), 2850.88 (C-H str., 
alkane), 1664.64 (C=O str.), 1450.52 (C=C, aromatic), 1600.97 (C=C str., 
alkenes), 1161.19 (C-N str.), 858.34 (C-H bending, alkenes).
N-[3-chloro-2-(3-nitrophenyl)-4-oxoazetidin-1-yl] undec-10-
enamide (15)
Bp (°C) 105-110; yield 65%;1H NMR (CDCl3): δ 8.19 (s, 1H), 6.85-7.67 
(m, 4H), 5.61-5.64 (m, 1H), 5.42 (d, 1H), 5.11 (t, 1H), 4.67-4.77 (d, 2H), 
2.50-2.72 (m, 2H), 2.30 (t, 2H), 1.50-1.54 (m, 2H), 1.18-1.24 (m, 10H). IR 
(KBr pellets) cm−1: 3448.84 (NH str.), 2968.55 (C-H str., aliphatic), 1639.55 
(C=C alkenes), 1656.91 and 1732.13 (C=O str.), 1529.60 and 1346.36 (N-H 
bending), 1454.38 (C=C, aromatic), 1369.50 (N=O str.), 615.31 (C-Cl str.).
N-(3-chloro-2-(3-flourophenyl)-4-oxoazetidin-1-yl) undec-10-
enamide (16)
Bp (°C) 118-123; yield 55%; 1H NMR (DMSO): δ 8.16 (s, 1H), 6.80-7.35 
(m, 4H), 5.61-5.64 (m, 1H), 5.40 (d, 1H), 5.07 (t, 1H), 4.67-4.77 (d, 2H), 
2.50-2.72 (m, 2H), 2.30 (t, 2H), 1.50-1.54 (m, 2H),1.18-1.24 (m, 10H) 
IR (KBr pellets) cm−1:3443.05 (NH str.), 2926.11 (C-H str., aliphatic), 
1718.63 and 1735.99 (C=O str.), 1633.76 (C=C alkenes), 1604.83 (N-H 
bending), 1560 & 1437 (C=C, aromatic), 1373.36 (C-F str.), 761.91 (C-Cl).
3-methyl-1-(undec-10-enoyl)-1H-pyrazol-5(4H)-one (17)
Mp (°C) 238-243; Yield 52%; 1H NMR (DMSO): δ 5.77- 5.80 (d, 2H), 
4.03-4.17 (m, 1H), 2.01-2.18 (m, 2H), 2.34 (t, 2H), 1.30-1.34 (m, 2H), 
1.77 (s, 3H), 1.90-2.10 (d, 2H), 1.16-1.29 (m, 10H) IR (KBr pellets) 
cm−1: 3421.83 and 3223.16 (NH str.), 3072.71 (C-H str. alkenes), 2850.88 
(C-H str., alkane), 2360.95 (C=N str.), 1656.91 and 1710.92 (C=O str.), 
1442.80 (CH2 bend), 1313.57 (C-N str.).
2-(Dec-9-en-1-yl)-5-methyl-1,3,4-oxadiazole (18)
Mp (°C) 45-61%; yield 65%; 1H NMR (CDCl3): δ 5.67-5.74 (d, 2H), 4.83-4.93 
(m, 1H), 2.05-2.19 (m, 2H), 2.56 (t, 2H), 1.32 (m, 2H), 2.68 (s, 3H), 1.21-
1.29 (m, 10H) IR (KBr pellets) cm−1: 3076.56 (C-H str., alkenes), 2928.04 
(C-H str., aliphatic), 2254.86 (C=N str.), 1739.85 (C=O str.), 1641.48 (C=C, 
alkenes), 1458.23 (C-H bending, aliphatic), 976.01 (C-H bending, alkenes).
N′-acetylundec-10-enehydrazide (19)
Mp (°C) 184-189; yield 64%; 1H NMR (CDCl3): δ 9.63-9.71(d, 1H), 9.43-
9.45 (d, 1H), 5.68-5.78 (m, 1H), 4.82-4.90 (m, 2H), 2.02-2.43 (m, 2H), 
2.60 (t, 2H), 1.50-1.53 (m, 2H), 1.33-1.54 (m, 10H), 1.21(s, 3H). IR (KBr 
pellets) cm−1: 3462.34 & 3221.23 (NH str.), 3032.20 (C-H str., alkenes), 
2856.67 (C-H str., aliphatic), 1720 (C=O str.), 1654.98 (C=C, alkenes), 
1641.48 (NH bending), 1371.43 (C-H bending, aliphatic), 910.43 (C-H 
bending, alkenes).
Antimicrobial studies
“The antimicrobial activity of synthesized derivatives (2-19) was 
performed against Gram-negative bacteria: E. coli; Gram-positive 
bacteria: S. aureus, B. subtilis; and fungal strains: A. fumigatus and 
A. niger by tube dilution method. Ciprofloxacin and fluconazole were 
used as a standard drug for antibacterial and antifungal activities. 
The standard and test samples were dissolved in DMSO to give a 
concentration of 100 µg/ml. Dilutions of test and standard compounds 
were prepared in double strength nutrient broth – I.P. (bacteria) or 
Sabouraud dextrose broth I.P. (fungi) [33]. The samples were incubated 
at 37°C for 24 hrs (bacteria), at 25°C for 7 days (A. niger) and at 37 
°C for 48 hr (A. fumigatus), and the results were recorded in terms of 
minimum inhibitory concentration (MIC) (the lowest concentration of 
test substance which inhibited the growth of microorganisms) by tube 
dilution method.” [11,34].
QSAR studies
The QSAR study was carried out to find out the relationship between 
physicochemical parameters and antimicrobial activity of synthesized 
undecylenic acid hydrazide derivatives. The structures of synthesized 
derivatives were first preoptimized with the molecular mechanics 
force field method (MM+) included in hyperchem 6.0 (1993) [35], 
and the resulting geometries were further refined by means of the 
semiempirical method PM3 (parametric method-3). Gradient norm 
limit of 0.01 kcal/Å was utilized for the geometry optimization. 
TSAR 3.3 software for Windows (2000) [36] was used to calculate 
physicochemical parameters of lowest energy structures of synthesized 
derivatives. Further, the regression analysis and development of 
QSAR models was performed using the TSAR 3.3 software. The 
predictive powers of the developed models were supported by cross-
validated r2 (q2) using leave one out (LOO) cross-validation method 
[37]. The statistical qualities of equations were further confirmed 
by the parameters such as standard error of estimate (s), correlation 
coefficient (r), variance ratio (F) at specified degrees of freedom.
Molecular docking
Molecular docking studies were carried out to understand the binding 
pattern of synthesized compounds and to support the data of in vitro 
antimicrobial activity. The two-dimensional structure of ligand was 
drawn on ChemBioDraw ultra 12.0, and three-dimensional (3D) 
coordinates were developed using ChemBio3D ultra 12.0. The energy 
minimization was carried out by MM2 and finally by RHF/3-21G. 
Automated docking was used to determine the orientation of inhibitors 
bound in the active site of bacterial beta-ketoacyl-acyl carrier protein 
synthase III (FabH; pdb id:3IL7) [29,38]. An incremental construction 
algorithm method, implemented in the program FlexX embedded 
LeadIT, was employed. Ligand affinity calculations were performed 
using hyde (in LeadIT) assessment.
RESULTS AND DISCUSSION
Spectral data analysis
The synthesis of the intermediate (2, 3) and target compounds (4-19) 
was performed according to reactions outlined in Schemes 1 and 2. 
A methanolic solution of undecylenic acid 1 was refluxed in the presence 
of sulfuric acid to yield the methyl ester undecylenic acid (2). The 
methyl ester 2 was refluxed with hydrazine hydrate to yield undec-
10-ene hydrazide 3, which was condensed with corresponding 
aromatic aldehydes/acetophenone to synthesize the target undec-
10-ene hydrazide derivatives (4-13). Then, corresponding undec-10-
enehydrazide derivatives (4-6) was refluxed with chloroacetyl chloride 
and triethylamine in dioxane to produce azetidinone derivatives 
(14-16). The undec-10-ene hydrazide 3 was also reacted with ethyl 
acetoacetate; acetic acid in acetic anhydride and acetic anhydride to yield 
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corresponding hydrazide derivatives (17-19). The physicochemical 
characteristics of synthesized compounds are presented in Table 1.
Structures of synthesized compounds (2-19) were ascertained on the 
basis of their 1H NMR and IR spectral data. The presence of two singlet 
peaks for NH and NH2 at δ 3.88 ppm and δ 7.49 ppm, respectively, 
revealed the formation of undec-10-ene hydrazide 3. The appearance 
of singlet signal ranging from δ 7.49 to 10.72 ppm in the synthesized 
compounds (4-16) confirmed the presence of NH of hydrazide 
derivatives. The appearance of singlet signal of CH proton in compounds 
5 at δ 7.92 ppm revealed the formation of N=CH bond in the synthesized 
derivative. The presence of aromatic protons was confirmed by the 
multiplet signal in the range of δ 6.80-8.20 ppm. The absence of -NH2 
protons in the region of δ 3-4 ppm in synthesized compounds (4-19), 
whereas the presence of same in compound 3 at δ 3.88 ppm further 
confirmed the synthesis of hydrazone and azetidinone derivatives. The 
appearance of singlet peak of CH proton at δ 1.77 ppm depicted the 
formation of pyrazole-5-one ring in compound 17. The appearance of 
two doublet peak of NH proton in the range of δ 9.63-9.71 and 9.43-
9.45 ppm revealed the formation of compound 19. The presence of 
singlet peak at δ 3.73 and 3.80 ppm confirmed the presence of methoxy 
groups in compound 8 and 10, respectively.
The presence of the C=O functional group in compound 2 was indicated 
by the appearance of a stretching band around 1741 cm−1, which is 
the characteristic of an ester linkage. Further, the presence of the C=O 
stretching of amide group was indicated by the appearance of a band 
around 1631 cm−1 (3-20). The presence of the C=C str. aromatic was 
Scheme 1: Synthetic scheme for synthesis of hydrazone and azetidinone derivatives of undecylenic acid
Compound R1 R2 R3 R4 R5
4 H H H H H
5 H NO2 H H H
6 H F HS H H
7 H OH H H H
8 H OCH3 OCH3 H H
9 H OH OCH3 H
10 H OH OC2H5 H H
11 H H H H H
12 H OH H H H
13 H OH H OH H
14 H H H H H
15 H NO2 H H H
16 H F H H H
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indicated by the appearance of a stretching band around 1600 cm−1 
in compounds (4-20). The appearance of IR band around 3200-3500 
cm−1 showed the presence of NH linkage of amide bond of hydrazide 
derivatives. The appearance of C–F, bands at 1294 and 1373 cm−1 in 
compounds 6 and 16 indicated the presence of fluoro groups in their 
structures, respectively. In compounds 8, 9 and 10 stretching at around 
1271-1290 cm−1 (asymmetric C–O–C stretching) and 1107-1122 cm−1 
(symmetric C–O–C stretching) revealed the presence of methoxy and 
ethoxy groups. Further, the aromatic nitro stretching around 1338 cm−1 
(symmetric NO2 stretching) and 1521 cm−1 (asymmetric NO2 stretching) 
depicted the presence of nitro functional group in synthesized compounds 
5 and 15. The presence of two C=O functional groups were indicated 
by the appearance of band at 1718.65 and 1735.35 cm−1, which is the 
characteristics of azetidinones (16). Further, the appearance of IR band 
around 3200-3300 cm−1 showed the presence of NH linkage of azetidinone 
ring. The synthesis of compounds 4 and 8 was further confirmed by 
molecular ion peak at m/z 287.2 and 347.2 in mass spectra, respectively.
Antimicrobial activity evaluation
The synthesized undec-10-ene-hydrazide derivatives were evaluated 
for their in vitro antibacterial activity against Gram-positive S. aureus, 
B. subtilis; Gram-negative E coli; and antifungal activity against 
A. fumigatus and A. niger by tube dilution method [34]. Double 
strength Nutrient broth I.P. and Sabouraud dextrose broth I.P. have 
been employed as media for growth of bacterial and fungal cells, 
respectively [33]. The results of antimicrobial activity (in µM/ml) are 
presented in Table 2.
In case of B. subtilis, compounds 5, 8, 9, 10, 14, and 15 were found to 
be more active than the other synthesized derivatives having pMIC 
value in the range of 1.43-1.52 (Table 2). Compound 15 having m-NO2 
substituted phenyl ring at third position of 2-azetidinone ring was found 
to be most active against B. subtilis with pMIC value of 1.52 among the 
synthesized derivatives. Against S. aureus, compounds 5, 8, 9 10, 11, and 
13 were found to be more active than the other synthesized derivatives 
having pMIC value in the range of 1.40-1.44 (Table 2). Results of 
antimicrobial activity depicted the significance of NO2 (5), OCH3, or 
OC2H5 and OH groups (8, 9, 10 and 13) in improving antibacterial 
activity against S. aureus. Further, compounds 8, 11, 13, and 14 were 
found to be most potent against the Gram-negative bacteria, E. coli 
having pMIC value 1.44, 1.40, 1.42 and 1.47, respectively (Table 2). 
Structure activity relationship study of synthesized undecylenic acid 
Scheme 2: Synthetic scheme for synthesis of hydrazide derivatives of undecylenic acid
Table 1: Physicochemical properties of synthesized hydrazide derivatives
Compounds Molecular formula Molecular weight Mp/Bp*(°C)  Rf % yield
2 C12H22O2 198 103-108* 0.71a 80
3 C11H22N2O 198 88-93 0.52b 72
4 C18H26N2O 286 88-93 0.60b 64
5 C18H25N3O3 331 115-120 0.63b 72
6 C18H25FN2O 304 210-215 0.71b 50
7 C18H26N2O2 302 77-82 0.65b 68
8 C20H30N2O3 346 210-215 0.67b 50
9 C19H28N2O3 332 104-109 0.69b 55
10 C20H30N2O3 346 215-220 0.40b 65
11 C19H28N2O 300 120-125 0.67b 50
12 C19H28N2O2 316 115-120 0.65b 55
13 C19H28N2O3 332 145-150 0.53e 48
14 C20H27 ClN2O2 362 113-119* 0.50c 53
15 C20H26ClN3O4 407 105-110* 0.85d 65
16 C20H26ClFN3O2 380 118-123* 0.65d 55
17 C15H24N2O2 264 238-243 0.69b 52
18 C13H22N2O 222 45-61 0.70b 65
19 C13H24N2O2 240 184-189 0.80b 64




 Kumari et al. 
hydrazide derivatives showed the importance of electron donating 
groups, viz., OCH3 (8) and OH (13) inactivity against E. coli.
On the other hand in case of A. fumigatus, compounds 15 and 16 and were 
found to be more active than the other synthesized derivatives having 
pMIC 1.52 and 1.49 (Table 2). SAR study of synthesized derivatives 
against A. fumigatus showed the presence of meta electron withdrawing 
substituted NO2 and F phenyl moiety at 2-azetidinone (15 and 16) ring is 
important for their antifungal activity. Moreover, comparing antifungal 
activity of different azetidinones revealed the significance of electron 
withdrawing groups at meta position of phenyl ring (viz., NO2 and F 
groups) against A. fumigatus. Role of electron withdrawing groups in 
antifungal activity against A. fumigatus is as follow: NO2> F >H.
In case of A. niger, compound 16 was found to be active than the 
other synthesized derivatives having pMIC value of 1.49. Analysis 
of antifungal results indicated the importance of p-fluoro phenyl 
substituted azetidinone (16) moiety in improving antifungal activity 
against A. niger.
Structure activity relationship
1. The analysis of antimicrobial results indicated that compound having 
dimethoxy groups eight was endowed with high antimicrobial 
activity. The importance of electron-donating groups in enhancing 
the antimicrobial activity is supported by similar results observed 
by Emami et al. [39].
2. The introduction of OH group (9 and 10) in phenyl moiety led to an 
increased antimicrobial activity (pMIC 1.43 and 1.44, respectively) 
except E. coli. This observation revealed the fact that the presence 
of an OH group increases the antifungal activity probably by 
forming hydrogen bond with the target site. This fact is supported 
by the observations of Vicini et al. [40], in contrary, compounds 9 
and 10 showed less activity against E. coli (pMIC = 1.12 and 1.14, 
respectively).
3. The presence of an electron-withdrawing NO2 group makes the 
synthesized derivatives (5 and 15) highly potent antibacterial and 
antifungal agents. Moreover, the presence of both azitidinone and 
NO2 moieties in compound 15 (pMIC=1.34) further enhanced the 
activity as compared to compound 5 (pMIC=1.31). The role of an 
electron-withdrawing group in increasing the antimicrobial potency 
is similar to the results of Sharma et al. [41].
4. The presence of electron-withdrawing m-fluoro phenyl group 
in azetidinone derivatives 16 enhances the growth inhibition 
potency against both tested fungal strains, A. fumigatus and A. niger 
(pMIC=1.49). Whereas, compound 15 having m-nitro phenyl group 
in azetidinone was found be active against A. fumigatus (pMIC=1.52).
5. The replacement of NH2 group in compound 3 with benzylidene 
(1-13) and 2-azetidinone moieties (13-16) led to a noticeable 
increase in antimicrobial activity of the synthesized compounds. 
This may be due to the increase in lipophilicity of the molecules 
which may allow them to easily penetrate the microbial membrane. 
Moreover, azitidinone ring containing compounds are well known 
for their inhibition of cell wall synthesis ability [42].
6. Aforementioned results showed that different types of substitutions 
are necessary for a molecule to have antibacterial or antifungal 
properties. Similar types of results were reported by Sortino 
et al. [43]. The SAR studies are represented in Figs. 1 and 2.
QSAR studies
Development of ot-QSAR models
QSAR is one of the most influential methods for the prediction of 
biological activity of compounds. QSAR technique is also important in 
finding quantitative relationships between the molecular structure and 
biological activity of investigated compounds [44]. In this study, we have 
performed the QSAR studies by Hansch’s analysis using the linear free 
energy relationship (LFER) model described by Hansch and Fujita [45].
In Hansch’s approach, structural properties of compounds are calculated 
in terms of different physicochemical parameters and these parameters 
are correlated with biological activity through equation using regression 
analysis. Before using the biological activity data for QSAR study 
experimentally determined MIC values changed to –log MIC or pMIC (in 
micromole) to get all the values positive, normal distribution of errors 
and to get LFER of these data with physicochemical parameters. Further, 
regression analysis was performed using calculated physicochemical 
parameters (Table 3) as independent variables and antimicrobial 
activity values as dependent variables (Table 2). The reference drugs 
ciprofloxacin and fluconazole were not included in model generation as 
they belong to different structural series.
On the basis of intercorrelation between the independent variables 
and also their individual correlation with antimicrobial activity 
Table 2: pMIC values of synthesized hydrazides derivatives
Compounds pMIC (µM/mL)
Bacillus subtilis Staphylococcus aureus Escherichia coli Aspergillus 
fumigatus
Aspergillus niger ab af am
1 1.17 0.87 0.87 1.17 0.87 0.97 1.02 0.99
2 1.20 0.90 0.90 1.20 1.20 1.0 1.20 1.08
3 1.20 0.90 1.20 1.20 0.90 1.1 1.05 1.08
4 1.37 1.06 1.37 1.37 1.06 1.26 1.21 1.24
5 1.43 1.43 1.12 1.43 1.12 1.33 1.28 1.31
6 1.39 1.39 1.09 1.39 1.09 1.29 1.24 1.27
7 1.08 1.08 1.08 1.39 1.39 1.08 1.39 1.20
8 1.44 1.44 1.44 1.39 1.39 1.44 1.39 1.42
9 1.43 1.43 1.12 1.43 1.43 1.33 1.43 1.37
10 1.44 1.44 1.14 1.44 1.44 1.34 1.44 1.38
11 1.39 1.40 1.40 1.39 1.39 1.39 1.39 1.39
12 1.08 1.08 1.08 1.39 1.39 1.08 1.39 1.20
13 1.12 1.42 1.42 1.42 1.42 1.32 1.42 1.36
14 1.47 1.17 1.47 1.47 1.17 1.37 1.32 1.35
15 1.52 1.21 1.21 1.52 1.21 1.32 1.37 1.34
16 1.19 1.19 1.19 1.49 1.49 1.19 1.49 1.31
17 1.33 1.03 1.03 1.33 1.33 1.13 1.33 1.21
18 1.25 0.96 0.66 1.25 1.25 0.96 1.25 1.07
19 1.29 0.92 1.29 1.29 1.29 1.17 1.29 1.22
SD 0.14 0.21 0.21 0.10 0.18 0.15 0.13 0.12
Std. 2.61a 2.61a 2.61a 2.64b 2.64b 2.61 2.64 2.62
SD: Standard deviation, aCiprofloxacin, bFluconazole
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Fig. 1: Structural requirement for the antibacterial and antifungal activities of undecylenic acid hydrazide derivatives
Fig. 2: Structural requirements for the antibacterial and antifungal activities of azetidinone derivatives
Table 4: Correlation matrix for pMICaff with molecular descriptors
Log P MR 0χ 1χ 2χ 3χ κ1 κα1 R B W LUMO HOMO aff
Log P 1.000
MR 0.801 1.000
0χ 0.751 0.988 1.000
1χ 0.788 0.995 0.997 1.000
2χ 0.760 0.975 0.992 0.990 1.000
3χ 0.522 0.806 0.876 0.850 0.912 1.000
κ1 0.726 0.982 0.990 0.985 0.966 0.826 1.000
κα1 0.723 0.984 0.989 0.985 0.965 0.824 0.999 1.000
R 0.749 0.989 0.976 0.979 0.951 0.774 0.983 0.987 1.000
B −0.871 −0.869 −0.836 −0.865 −0.870 −0.718 −0.781 −0.791 −0.824 1.000
W 0.722 0.966 0.951 0.954 0.913 0.720 0.969 0.977 0.988 −0.771 1.000
LUMO −0.760 −0.819 −0.819 −0.828 −0.840 −0.744 −0.795 −0.789 −0.750 0.836 −0.697 1.000
HOMO 0.580 0.620 0.543 0.567 0.466 0.149 0.619 0.631 0.688 −0.478 0.736 −0.339 1.000
Aff 0.768 0.971 0.981 0.983 0.989 0.883 0.956 0.953 0.944 −0.866 0.898 −0.837 0.468 1.000
LUMO: Lowest unoccupied molecular orbital, HOMO: Highest occupied molecular orbital
Table 3: Values of selected descriptors of synthesized undec-10-enoic acid hydrazide derivatives used in LR and MLR analysis
Compounds MM Log P 0χ 1χ 2χ 2χv κ1 κα1 R B W LUMO HOMO
1 184.31 3.42 9.94 6.27 4.66 3.34 13.00 12.37 14.09 6.89 2732.00 1.02 −10.04
2 198.34 3.45 10.65 6.81 4.78 3.52 14.00 13.37 15.23 6.89 3554.00 1.14 −10.02
3 198.35 2.54 10.65 6.81 4.78 3.52 14.00 13.33 15.37 6.94 3525.00 1.01 −10.03
4 286.46 5.10 15.18 10.33 7.80 5.15 19.05 17.71 20.49 3.47 7958.00 −0.32 −8.97
5 331.46 5.05 17.62 11.63 9.34 5.59 22.04 20.27 21.41 3.48 8954.00 −1.23 −9.48
6 304.45 5.24 16.05 10.72 8.44 5.30 20.05 18.64 20.49 3.47 7958.00 −0.38 −9.02
7 302.46 4.81 16.05 10.72 8.44 5.34 20.05 18.67 21.03 3.47 8455.00 −0.24 −8.82
8 346.52 4.59 18.33 12.21 9.32 5.86 23.04 21.62 23.86 3.51 12478.00 −0.14 −8.36
9 332.49 4.56 17.62 11.67 9.12 5.67 22.04 20.62 22.72 3.47 10756.00 −0.20 −8.52
10 346.52 4.90 18.33 12.17 9.50 5.90 23.04 21.62 23.97 3.47 12688.00 −0.17 −8.48
11 300.49 4.73 16.05 10.74 8.32 5.55 20.05 18.71 21.71 3.62 9170.00 −0.07 −9.08
12 316.49 4.45 16.92 11.13 8.96 5.73 21.04 19.67 22.24 3.62 9688.00 −0.16 −9.06
13 332.49 4.16 17.79 11.54 9.48 5.88 22.04 20.62 22.78 3.66 10212.00 −0.14 −8.94
14 362.94 4.87 18.07 12.15 9.96 6.96 21.30 19.83 22.63 2.63 9860.00 −0.02 −9.68
15 407.94 4.83 20.52 13.45 11.49 7.40 24.27 22.36 23.54 2.63 10926.00 −1.31 −10.04
16 380.93 5.01 18.94 12.54 10.60 7.10 22.29 20.75 22.63 2.63 9860.00 −0.29 −9.69
17 264.41 3.78 14.09 9.15 7.46 5.06 17.05 16.17 18.40 3.63 5842.00 0.02 −9.90
18 222.37 3.94 11.64 7.83 6.05 4.16 14.06 13.90 16.31 3.60 4173.00 −0.02 −9.98
19 240.39 2.17 12.93 8.16 6.34 4.18 17.00 16.00 17.49 6.93 5218.00 0.57 −10.05
LUMO: Lowest unoccupied molecular orbital, HOMO: Highest occupied molecular orbital
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Tables 4 and 5, different probable combinations of parameters were 
subjected to linear regression (LR) and multiple LR analysis. Out of 
hundreds of equations generated, some of the best QSAR equations 
having significant statistical values are selected. These equations were 
generated in stepwise manner by forward selection method starting 
with best single variable and adding further significant variable 
according to their contribution to the model that leads to the smallest 
standard deviation (s) until there is no other variable outside the 
equation that satisfies the selection criteria.
The different physicochemical parameters, viz., topological, electronic, 
thermodynamic, and spatial [45-51], were quantified using TSAR 3.3 
software (2000) for synthesized derivatives are summarized in Table 3.
In view of above facts, a data set of 19 synthesized undecylenic acid 
hydrazide derivatives was used for model development. The predictive 
powers of derived QSAR models were confirmed by LOO method [37], 
where a model is built with N - 1 compounds and Nth compound is 
predicted. Each compound is eliminated for model derivation and 
predicted in turn. The same procedure is repeated after elimination of 
another compound until all the compounds have been eliminated once.
A correlation matrix constructed for antibacterial activity against 
A. fumigatus is presented in Table 4. Both high and low colinearity was 
observed between different physicochemical properties. A highest 
interrelationship was observed between 1χ and 0χ (r=0.997), and 
lowest interrelationship was observed between 3χ and highest energy 
occupied molecular orbital (HOMO) (r=0.149). The correlations of 
different parameters with antimicrobial activities are presented in 
Table 5. A significant correlation (r>0.7) was observed against all tested 
microbial strains with most of selected parameters except HOMO 
(Table 5).
ot-QSAR model for antibacterial activity against S. aureus
pMICsa=0.181W+1.175 (Eq. 1)
n=19 r=0.839 q2=0.682 s=0.120 F=40.457
ot-QSAR model (Eq. 1) showed that antibacterial activity of S. aureus 
is positively correlated with Weiner topological index (W). This can be 
clearly seen from Table 3, compounds 8, 9 and 10 with high W values 
have highest antibacterial activity (pMICsa=1.43-1.44) (Table 2), 
whereas in case of compounds 1-3 with low W values have lowest 
antibacterial activity (pMICsa range=0.87-0.90). Further, for S. aureus 
biparametric model (Eq. 2) was developed by combination W and 
HOMO, and there is slight increase in value of r (from 0.839 [Eq. 1] to 
0.857 [Eq. 2]) and q2 (from 0.683 [Eq. 1] to 0.707 [Eq. 2]), thus increase 
in predictability QSAR models. Further, equation 2 revealed that, against 
S. aureus antibacterial of activity of synthesized derivatives enhances by 
increase in the value of W and HOMO.
pMICsa = 0.139 W + 0.056 HOMO + 1.175 (Eq. 2)
n=19 r=0.857 q2=0.707 s=0.117 F=22.234
Compounds 8, 9, and 10 have highest activity values (1.44, 1.43, and 
1.44, respectively; Table 2) with highest HOMO values, i.e., −8.36, −8.52, 
and −.8.48 (lowest negative value), respectively (Table 3). On the other 
side, compounds 1-3 (Table 2) have lowest pMICsa values with lowest 
HOMO values (highest negative values). The values of rand q2 for Eq. 2 
are 0.857 and 0.707, which means that the resulted QSAR model could 
explain and predict 85.7% and 70.7% of variances, respectively.
ot-QSAR model for antibacterial activity against E. coli
pMICec=0.127 R+1.162 (Eq. 3)
n=19 r=0.604 q2=0.256 s=0.173 F=9.740
In case of E. coli developed, QSAR model (Eq. 3) showed positive 
correlation with Randic topological index (R). Compounds 8, 11, 
13, and 14 showed highest activity (pMIC range=1.40-1.47) against 
E. coli comprising high values of R, i.e., 23.86, 21.71, 22.78, and 22.63, 
respectively. Whereas, compounds 1, 2, and 18 showed least activity 
against E. coli (Table 2) with low values of R (Table 3).
In general, when q2 is larger than 0.5, the model is considered to have 
sound predictive power. However, several studies recommended that a 
high q2 appear to be a necessary, but not sufficient, condition for a model 
to have a highly accurate predictive power [52]. Consequently, various 
other statistical approaches were used to validate the robustness and the 
practical applicability of the developed QSAR models. To demonstrate 
that the resulted equations have good prediction of antimicrobial 
activity of selected hydrazide derivatives, some different methods 
of evaluation of model performance have been used. Here, r2, which 
presents the explained variance for given set, was used to determine 
the goodness of model’s fit performance. Moreover, low residual values 
indicated that experimental and predicted antimicrobial activities are 
very close to each other also confirmed the robustness of developed 
models (Tables 6 and 7).
ot-QSAR model for antifungal activity against A. fumigatus
pMICaff=0.0992χ+1.366 (Eq. 4)
n=19 r=0.989 q2=0.969 s=0.015 F=776.988
Developed QSAR model (Eq. 4) revealed that antifungal activity of 
synthesized derivatives is directly proportional to second order 
molecular connectivity index (2χ) against A. fumigatus. Compounds 14, 
15, and 16 demonstrated highest potency (pMIC values 1.47, 1.52, and 
1.49, respectively; Table 2) have highest value of 2χ (9.96, 11.49, and 
Table 5: Correlation of different molecular descriptors with antimicrobial activity of undecanoic acid derivatives
Descriptor Bacillus subtilis Staphylococcus aureus Escherichia coli Aspergillus 
fumigatus
Aspergillus niger ab af am
Log P 0.387 0.683 0.226 0.768 0.316 0.547 0.534 0.608
MR 0.461 0.800 0.569 0.971 0.580 0.792 0.807 0.898
0χ 0.454 0.779 0.554 0.981 0.582 0.775 0.814 0.889
1χ 0.467 0.783 0.550 0.983 0.575 0.778 0.809 0.889
2χ 0.432 0.730 0.510 0.989 0.568 0.725 0.808 0.850
3χ 0.282 0.525 0.372 0.883 0.517 0.520 0.731 0.672
κ1 0.451 0.818 0.585 0.956 0.586 0.807 0.807 0.910
Kα1 0.448 0.824 0.572 0.953 0.612 0.803 0.824 0.913
R 0.426 0.819 0.604 0.944 0.644 0.806 0.841 0.922
B 0.392 0.646 0.283 0.866 0.521 0.562 0.721 0.693
W 0.449 0.839 0.582 0.898 0.638 0.812 0.819 0.918
LUMO 0.488 0.643 0.242 0.837 0.324 0.577 0.573 0.646
HOMO 0.169 0.737 0.386 0.468 0.506 0.579 0.546 0.637
LUMO: Lowest unoccupied molecular orbital, HOMO: Highest occupied molecular orbital
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10.60, respectively; Table 3). Further, the presence of predicted and 
observed values (Fig. 3) close to each other confirmed the robustness 
of developed QSAR Eq. 4. Moreover, the presences of residual values on 
both side of zero revealed there is no systemic error exists in developed 
QSAR model (Fig. 4 and Table 6).
ot-QSAR model for antifungal activity against A. niger
pMICan=0.117R+1.254 (Eq. 5)
n=19 r=0.644 q2=0.376 s=0.143 F=12.021
In case of A. niger developed QSAR model (Eq. 5) indicated the 
importance of Randic topological index (R) and the results are similar 
as in case of E. coli. In present both cases (Eqs. 3 and 5) value of r is less, 
demonstrated that predictability of developed QSAR model is less as 
compared to other developed QSAR models, where values of r are more 
(Eqs. 1, 2 and 4).
Development of mt-QSAR models
“According to the above ot-QSAR models one should use five different 
equations with different errors to predict the activity of a new compound 
against the five microbial species. The ot-QSAR models, which are almost 
in all the literature, become unpractical or at less complicated to use 
when we have to predict to each compound results for more than one 
target. In these cases, we have to develop one ot-QSAR for each target. 
However, recently the interest has been increased in the development 
of mt-QSAR models. In opposition to ot-QSAR, the mt-QSAR model is 
a single equation that considers the nature of molecular descriptors 
which are common and essential for describing the antibacterial 
and antifungal activity [53-57].” Methods used to calculate average 
values of antibacterial [pMICab=pMICbs+pMICsa+pMICec/3], antifungal 
[pMICaf=pMICan+pMICaff/2] and overall antimicrobial activities 
[pMICam=pMICbs+pMICsa+pMICec+pMICan+pMICaff/5] and mt-QSAR 
models are described in our previous studies [5-10,58].
mt-QSAR model for antibacterial activity
pMICab=0.122W+1.214 (Eq. 6)
n=19 r=0.812 q2=0.631 s=0.090 F=33.003
Similar to S. aureus (Eq. 1), overall antibacterial activity is also 
governed by W (Eq. 6). Compound 8 with maximum antibacterial 
potency (pMICab=1.44) (Table 2) have the highest value of W (12478) 
Fig. 3: Plot of predicted pMICaff  values against observed pMICaff 
values for the model developed by Eq. 4
Fig. 4: Plot of residual pMICaff  values against observed pMICaff 
values for the model developed by Eq. 4
Table 6: Comparison of observed and predicted antibacterial and antifungal activity obtained by ot − QSAR models
Compounds pMICsa (Eq. 2) pMICec (Eq. 3) pMICaff (Eq. 4) pMICan (Eq. 5)
Observed Predicted Res. Observed Predicted Res. Observed Predicted Res. Observed Predicted Res.
1 0.87 0.87 0.00 0.87 0.91 −0.04 1.17 1.19 −0.02 0.87 1.02 −0.15
2 0.90 0.91 −0.01 0.90 0.96 −0.06 1.20 1.20 0.00 1.20 1.07 0.13
3 0.90 0.91 −0.01 1.20 0.96 0.24 1.20 1.20 0.00 0.90 1.07 −0.17
4 1.06 1.21 −0.15 1.37 1.17 0.20 1.37 1.35 0.02 1.06 1.26 −0.20
5 1.43 1.20 0.23 1.12 1.20 −0.08 1.43 1.43 0.00 1.12 1.29 −0.17
6 1.39 1.20 0.19 1.09 1.17 −0.08 1.39 1.38 0.01 1.09 1.26 −0.17
7 1.08 1.24 −0.16 1.08 1.19 −0.11 1.39 1.38 0.01 1.39 1.28 0.11
8 1.44 1.47 −0.03 1.44 1.30 0.14 1.39 1.42 −0.03 1.39 1.38 0.01
9 1.43 1.38 0.05 1.12 1.26 −0.14 1.43 1.42 0.01 1.43 1.34 0.09
10 1.44 1.47 −0.03 1.14 1.31 −0.17 1.44 1.43 0.01 1.44 1.39 0.05
11 1.40 1.25 0.15 1.40 1.22 0.18 1.39 1.37 0.02 1.39 1.30 0.09
12 1.08 1.28 −0.20 1.08 1.24 −0.16 1.39 1.41 −0.02 1.39 1.32 0.07
13 1.42 1.31 0.11 1.42 1.26 0.16 1.42 1.43 −0.01 1.42 1.34 0.08
14 1.17 1.23 −0.06 1.47 1.25 0.22 1.47 1.46 0.01 1.17 1.34 −0.17
15 1.21 1.24 −0.03 1.21 1.29 −0.08 1.52 1.53 −0.01 1.21 1.37 −0.16
16 1.19 1.23 −0.04 1.19 1.25 −0.06 1.49 1.49 0.00 1.49 1.34 0.15
17 1.03 1.02 0.01 1.03 1.08 −0.05 1.33 1.33 0.00 1.33 1.18 0.15
18 0.96 0.94 0.02 0.66 1.00 −0.34 1.25 1.26 −0.01 1.25 1.11 0.14
19 0.92 0.98 −0.06 1.29 1.05 0.24 1.29 1.28 0.01 1.29 1.15 0.14
MIC: Minimum inhibitory concentration, QSAR: Quantitative structure–activity relationship
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(Table 3) among the synthesized compounds. On the other side, 
compounds 1 and 18 with lowest pMICab values (pMICab=0.97 and 
0.96) (Table 2) have a minimum value of W, i.e., 2732 and 4173 
(Table 3).
mt-QSAR model for antifungal activity
pMICaf=0.106R+1.311 (Eq. 7)
n=19 r=0.841 q2=0.636 s=0.070 F=41.189
In the case of antifungal activity, developed mt-QSAR model (Eq. 7) 
depicted the importance of R. Compound 16 was found to be most 
potent antifungal compound (pMICaf=1.49) (Table 2) among the 
synthesized derivatives comprising a high value of R (22.63) (Table 3). 
Whereas, compound 1 (pMICaf=1.02) (Table 2) with lowest antifungal 
potency have the lowest value of R (14.09) (Table 3).
mt-QSAR model for overall antimicrobial activity
pMICam=0.116R+1.252 (Eq. 8)
n=19 r=0.922 q2=0.836 s=0.050 F=92.925
Developed QSAR model (Eq. 8) revealed that overall antimicrobial 
activity of synthesized derivative is positively correlated with R. 
Compound 8 was found to be most potent (pMICam=1.42) (Table 2) 
among synthesized derivatives with a high value of R (23.86) (Table 3). 
On the other side, compound 1 with least potency (pMIC=0.99) 
(Table 2) have lowest R value (14.09) (Table 3). Further, the presence 
of predicted and observed value (Fig. 5) close to each other confirmed 
the robustness of developed QSAR Eq. 4. Moreover, the presence of 
residual values on both side of zero revealed no systemic error exists in 
developed QSAR model (Fig. 6 and Table 7).
Topological index (or molecular structure descriptor) is a numerical 
value associated with chemical molecule used for correlation of 
chemical structure with various physical properties, chemical reactivity 
or biological activity. One of the most important topological indexes is 
Randic index. It is also known as branching and connectivity index. It 
characterizes the branching in a chemical molecule. The mathematical 
formula for calculation of Randic index is:
1( )





d G d G
u and v represent the vertices of the molecular graph (G), vertices 
of the molecular graph represents a carbon atom. The number of 
Table 7: Comparison of observed and predicted antimicrobial activity obtained by mt−QSAR models
Compounds pMICab (Eq. 6) pMICaf (Eq. 7) pMICam (Eq. 8)
Observed Predicted Res. Observed Predicted Res. Observed Predicted Res.
1 0.97 1.00 −0.03 1.02 1.10 −0.08 0.99 1.03 −0.04
2 1.00 1.03 −0.03 1.20 1.14 0.06 1.08 1.07 0.01
3 1.10 1.03 0.07 1.05 1.14 −0.09 1.08 1.07 0.01
4 1.26 1.21 0.05 1.21 1.32 −0.11 1.24 1.26 −0.02
5 1.33 1.25 0.08 1.28 1.35 −0.07 1.31 1.29 0.02
6 1.29 1.21 0.08 1.24 1.32 −0.08 1.27 1.26 0.01
7 1.08 1.23 −0.15 1.39 1.33 0.06 1.20 1.28 −0.08
8 1.44 1.39 0.05 1.39 1.43 −0.04 1.42 1.38 0.04
9 1.33 1.32 0.01 1.43 1.39 0.04 1.37 1.34 0.03
10 1.34 1.40 −0.06 1.44 1.43 0.01 1.38 1.38 0.00
11 1.39 1.26 0.13 1.39 1.36 0.03 1.39 1.30 0.09
12 1.08 1.28 −0.20 1.39 1.37 0.02 1.20 1.32 −0.12
13 1.32 1.30 0.02 1.42 1.39 0.03 1.36 1.34 0.02
14 1.37 1.28 0.09 1.32 1.39 −0.07 1.35 1.34 0.01
15 1.32 1.33 −0.01 1.37 1.42 −0.05 1.34 1.37 −0.03
16 1.19 1.28 −0.09 1.49 1.39 0.10 1.31 1.34 −0.03
17 1.13 1.12 0.01 1.33 1.25 0.08 1.21 1.18 0.03
18 0.96 1.06 −0.10 1.25 1.18 0.07 1.07 1.11 −0.04
19 1.17 1.10 0.07 1.29 1.22 0.07 1.22 1.15 0.07
MIC: Minimum inhibitory concentration, QSAR: Quantitative structure–activity relationship
Fig. 5: Plot of predicted pMICam values against observed pMICam 
values for the model developed by Eq. 8
Fig. 6: Plot of residual pMICam values against observed pMICam 
values for the model developed by Eq. 8
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vertices of G adjacent to a given vertex v, is the “degree of vertex” 
and it is represented by dv(G). Molecular graph technique can be 
utilized to represent carbon-hydrogen skeleton of an organic 
compound [59].
Molecular docking evaluation
Ligand affinity calculations of most potent compound (8) were 
performed using Hyde (in LeadIT) assessment showed the better-
calculated score as −2.3. The pose view of conformation with highest 
docking score (−13.6762), binding energy DG (−32 KJ/mol), and 
ligand affinity (LE=31 mM) found to be better than cocrystallized 
ligand (Fig. 7). Docking study indicated hydrophobic interaction of 
deeply inserted aliphatic side chain of ligand with target site FabH. 
The N-atoms of hydrazide moiety interacts with Ala246 and Asn247 
through H-bonding. The m- and p-methoxy groups form H-bond with 
water and side chain of Arg36, respectively, so phenyl moiety oriented 
in such a way that it can participate in hydrophobic interactions with 
FabH.
CONCLUSION
A series of undec-10-enehydrazide derivatives were synthesized 
and tested against Gram-negative bacteria E. coli, Gram-positive 
bacteria B. subtilis, S. aureus, fungal strain A. niger and A. fumigatus 
by tube dilution method. QSAR and molecular modeling studies 
were performed to correlate antimicrobial activity with structural 
properties of synthesized molecules. Antimicrobial screening results 
showed that compound 8 having benzylidine moiety with methoxy 
groups at meta and para position and compound 16 having 3-chloro-
2-(3-flourophenyl)-4-oxoazetidin moiety was found to most potent 
antibacterial and antifungal compounds, respectively. Further, 
the analysis was performed by the development of multi and ot-
QSAR models. As compared to one target, mt-QSAR models were 
more effectual in relating the antimicrobial activity of synthesized 
derivative. In addition, QSAR studies revealed the importance of 
Randic topology parameter (R) in describing the antimicrobial 
activity of synthesized hydrazide derivatives. Molecular docking 
study indicated hydrophobic interaction of deeply inserted aliphatic 
side chain of the ligand with FabH. The N-atoms of hydrazide 
moiety interacts with Ala246 and Asn247 through H-bonding. The 
m- and p-methoxy groups (compound 8) form H-bond with water 
and side chain of Arg36, respectively, so phenyl moiety oriented in 
such a way that it can participate in hydrophobic interactions with 
the target site.
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